Wave Life Sciences Ltd. (NASDAQ:WVE)’s traded shares stood at 0.45 million during the last session, with the company’s beta value hitting -0.98. At the close of trading, the stock’s price was $4.87, to imply an increase of 1.46% or $0.07 in intraday trading. The WVE share’s 52-week high remains $7.67, putting it -57.49% down since that peak but still an impressive 35.32% since price per share fell to its 52-week low of $3.15. The company has a valuation of $595.50M, with an average of 894.70K shares over the past 3 months.

Wave Life Sciences Ltd. (NASDAQ:WVE) trade information

After registering a 1.46% upside in the last session, Wave Life Sciences Ltd. (WVE) has traded red over the past five days. The stock hit a weekly high of 5.91, jumping 1.46% in its intraday price action. The 5-day price performance for the stock is -16.03%, and -21.20% over 30 days. With these gigs, the year-to-date price performance is -3.56%.

Wave Life Sciences Ltd. (WVE) estimates and forecasts

Looking at statistics comparing Wave Life Sciences Ltd. share performance against respective industry, we note that the company has underperformed competitors. Wave Life Sciences Ltd. (WVE) shares are -13.35% down over the last 6 months, with its year-to-date growth rate lower than industry average at -74.07% against 13.30%.

WVE Dividends

Wave Life Sciences Ltd. has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Wave Life Sciences Ltd. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.